Dexlansoprazole – a new drug in general practice

Piotr Eder

eISSN: 2450-4459
ISSN: 2450-3517

Lekarz POZ

Current issue Archive Manuscripts accepted About the journal Supplements Abstracting and indexing Subscription Contact Instructions for authors

Editorial System

Submit your Manuscript

3/2017
vol. 3

Send email

Copy url:

abstract:

Review paper

Dexlansoprazole – a new drug in general practice

Piotr Eder

Online publish date: 2017/07/17

View full text Get citation

Proton pump inhibitors are commonly used in everyday clinical practice. Dexlansoprazole is a new-generation proton pump inhibitor with unique structure and pharmacokinetics. The dual-delayed-release system of dexlansoprazole prolongs inhibition of proton pump activity in parietal cells of the stomach. It can be dosed without regard to food intake or time of day. In the current paper data on the efficacy and safety of dexlansoprazole are presented, with emphasis on its utility in everyday clinical practice.

keywords:

Dexlansoprazole – a new drug in general practice

Piotr Eder

gastroesophageal reflux disease, proton pump inhibitors, dexlansoprazole